POWERED BY MOMENTUM MEDIA
Growth fund returns boosted by vaccine breakthroughs
COVID-19 vaccine breakthroughs have boosted share markets to help the median growth superannuation fund return 4.9% during November, according to Chant West.
Since the start of the year, funds with 61% to 80% in growth assets returned 2.6% and were set to finish the calendar year at around 3%.
Chant West senior investment research manager, Mano Mohankumar, said growth funds had made a 14.7% turnaround since the global sell-off in February and March that saw median growth funds plummet 12%.
“November’s surge in global share markets was driven mainly by reports of vaccine breakthroughs which gave investors a sense of light at the end of the tunnel and provided optimism around a return to some economic normality,” he said.
“Indeed, it was the more economically-sensitive sectors, including energy and financials, that experienced the biggest gains over the month. Additionally, Joe Biden’s US election victory removed much of the uncertainty that had been weighing on markets. In the Eurozone, infection rates fell in many countries resulting in the easing of restrictions.
“This year’s experience highlights to super fund members the importance of maintaining a long-term focus. Those who panicked and switched to cash or a more conservative option back in March would not only have crystallised losses, but as markets rebounded so sharply they would have missed out on some or all of the rebound.”
Recommended for you
Governor Bullock took a more hawkish stance on Tuesday, raising concerns over Trump’s escalating tariffs, which sent economists in different directions with their predictions.
Equity Trustees has announced the appointment of Jocelyn Furlan to the Superannuation Limited (ETSL) and HTFS Nominees Pty Ltd (HTFS) boards, which have oversight of one of the companies’ fastest growing trustee services.
Following growing criticism of the superannuation industry’s influence on capital markets and its increasing exposure to private assets, as well as regulators’ concerns about potential risks to financial stability, ASFA has released new research pushing back on these narratives.
A US-based infrastructure specialist has welcomed the $93 billion fund as a cornerstone investor.
TOP PERFORMING FUNDS
ACS FIXED INT - AUSTRALIA/GLOBAL BOND
Fund name
3y(%)pa
1
Global X GlobalX FANG+ ETF
33.51 3 y p.a(%)
2
Spire Oaktree Opportunities XI Second Close
32.68 3 y p.a(%)
3
DomaCom Lot 21 Chellaston Road Munno Para West SA 5115 Australia
31.62 3 y p.a(%)
4
Spire Oaktree Opportunities XI First Close USD
31.36 3 y p.a(%)
5
Fidante Credit Suisse Global Private Equity
29.60 3 y p.a(%)
